Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events

• Siqi Zhang,

  Roles Data curation, Methodology, Writing – original draft, Conceptualization

  Affiliations Department of Pharmacy, Nanjing Lishui People’s Hospital, Nanjing, China, Department of Medical Oncology, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China

  https://orcid.org/0009-0005-5065-8278

  ⨯
• Renmin Zhang,

  Roles Investigation, Software, Data curation

  Affiliation Department of Radiotherapy, Nanjing Lishui People’s Hospital, Nanjing, China

  ⨯
• Yingzi Xia,

  Roles Methodology, Visualization, Investigation

  Affiliation Department of Radiotherapy, Nanjing Lishui People’s Hospital, Nanjing, China

  ⨯
• Dingwen Cao

  Roles Writing – review & editing, Software

  * wenty730@163.com

  Affiliation Department of Pharmacy, Nanjing Lishui People’s Hospital, Nanjing, China

  ⨯